National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
1981
368
LTM Revenue n/a
LTM EBITDA n/a
$304M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
National Research has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, National Research achieved revenue of $143M and an EBITDA of $41.3M.
National Research expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See National Research valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $149M | $143M | XXX | XXX | XXX |
Gross Profit | $94.5M | $92.6M | XXX | XXX | XXX |
Gross Margin | 64% | 65% | XXX | XXX | XXX |
EBITDA | $46.7M | $41.3M | XXX | XXX | XXX |
EBITDA Margin | 31% | 29% | XXX | XXX | XXX |
Net Profit | $31.8M | $31.0M | XXX | XXX | XXX |
Net Margin | 21% | 22% | XXX | XXX | XXX |
Net Debt | n/a | $30.0M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, National Research's stock price is $11.
National Research has current market cap of $246M, and EV of $304M.
See National Research trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$304M | $246M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, National Research has market cap of $246M and EV of $304M.
National Research's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate National Research's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for National Research and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $304M | XXX | XXX | XXX |
EV/Revenue | 2.1x | XXX | XXX | XXX |
EV/EBITDA | 7.4x | XXX | XXX | XXX |
P/E | 9.9x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | 15.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpNational Research's NTM/LTM revenue growth is n/a
National Research's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, National Research's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate National Research's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for National Research and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | -4% | XXX | XXX | XXX | XXX |
EBITDA Margin | 29% | XXX | XXX | XXX | XXX |
EBITDA Growth | -12% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.4M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 36% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Beamtree | XXX | XXX | XXX | XXX | XXX | XXX |
Cogstate | XXX | XXX | XXX | XXX | XXX | XXX |
Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
Impedimed | XXX | XXX | XXX | XXX | XXX | XXX |
Proteomics International | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
National Research acquired XXX companies to date.
Last acquisition by National Research was XXXXXXXX, XXXXX XXXXX XXXXXX . National Research acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was National Research founded? | National Research was founded in 1981. |
Where is National Research headquartered? | National Research is headquartered in United States of America. |
How many employees does National Research have? | As of today, National Research has 368 employees. |
Who is the CEO of National Research? | National Research's CEO is Mr. Michael D. Hays. |
Is National Research publicy listed? | Yes, National Research is a public company listed on NAS. |
What is the stock symbol of National Research? | National Research trades under NRC ticker. |
When did National Research go public? | National Research went public in 1997. |
Who are competitors of National Research? | Similar companies to National Research include e.g. Beamtree, Cogstate, Echo IQ, Impedimed. |
What is the current market cap of National Research? | National Research's current market cap is $246M |
What is the current revenue growth of National Research? | National Research revenue growth between 2023 and 2024 was -4%. |
Is National Research profitable? | Yes, National Research is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.